Table 3 Quantile regression analysis of hospitalization costs in schizophrenics (CNY).
Variables | Hospitalization costs per time | Average daily hospitalization costs | ||||
|---|---|---|---|---|---|---|
Q10 | Q50 | Q90 | Q10 | Q50 | Q90 | |
Gender (contrast = male) | ||||||
 Female | −0.013 | −0.018** | 0.008* | −0.038** | −0.023** | −0.009 |
Age | −0.004** | −0.003** | −0.002** | −0.002** | −0.001** | 0.001** |
Payment method (contrast = medical insurance reimbursement) | ||||||
 Out-of-pocket | −0.044** | 0.053** | 0.044** | 0.073** | 0.074** | 0.089** |
Hospital nature (contrast = public) | ||||||
 Private | 0.557** | 0.158** | −0.079* | −1.051** | −1.064** | −1.090** |
Hospital level (contrast = provincial and municipal level) | ||||||
 District and county level and below | −0.814** | −0.341** | −0.175** | 0.788** | 0.683** | 0.631** |
Hospital type (contrast = general hospital) | ||||||
 Specialized hospital | 0.318** | 0.212** | 0.074** | 0.346** | 0.101** | −0.262** |
 TCM hospital | −0.448* | 0.080 | 0.170* | −0.296* | −0.023 | −0.172* |
 Primary medical and health institution | 0.912** | 0.805** | 1.283** | −0.550** | −0.104* | −0.060 |
Number of comorbidities (contrast = 0) | ||||||
 1 | 0.043 | 0.049** | 0.064** | 0.005 | 0.035** | 0.061** |
 2 | 0.055* | 0.129** | 0.184** | 0.042** | 0.083** | 0.074** |
 ≥3 | 0.107** | 0.245** | 0.248** | 0.164** | 0.188** | 0.173** |
Length of stay | 0.010** | 0.013** | 0.013** | −0.005** | −0.004** | −0.004** |
Proportion of medications | −0.026** | −0.020** | −0.012** | −0.027** | −0.019** | −0.007** |
Subtype (contrast = paranoid schizophrenia) | ||||||
 Hebephrenic schizophrenia | −0.259 | 0.058 | 0.195 | −0.099 | 0.188 | 0.841** |
 Catatonic schizophrenia | 0.048 | 0.041 | 0.059 | 0.046 | 0.076 | 0.016 |
 Undifferentiated schizophrenia | −0.003 | −0.018* | −0.007 | −0.009 | 0.004 | 0.006 |
 Post-schizophrenic depression | −0.654** | −0.393** | −0.147** | −0.570** | −0.356** | −0.085* |
 Residual schizophrenia | −0.046 | −0.206** | −0.130** | −0.283** | −0.021 | 0.148* |
 Simple schizophrenia | −0.178 | 0.091 | 0.537** | −0.344 | 0.237 | 0.129 |
 Other schizophrenia | −0.281 | −0.468 | −0.242 | 0.223 | 0.063 | 0.141 |
 Schizophrenia, unspecified | −0.471** | −0.212** | −0.099** | −0.320** | −0.103** | −0.028** |
Year (contrast = 2014) | ||||||
 2015 | 0.024 | 0.168** | 0.218** | 0.076** | 0.137** | 0.138** |
 2016 | 0.019 | 0.120** | 0.177** | 0.039* | 0.094** | 0.104** |
 2017 | 0.029 | 0.169** | 0.229** | 0.082** | 0.144** | 0.168** |
 2018 | −0.044* | −0.033** | −0.006 | −0.015 | −0.018* | 0.096** |
 2019 | 0.002 | −0.034** | 0.037** | −0.014 | −0.001 | 0.082** |
Pseudo R2 | 0.479 | 0.529 | 0.542 | 0.637 | 0.287 | 0.156 |